Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
Enanta Pharmaceuticals (ENTA) Ownership Overview
4.76% Insiders
11.99% Mutual Funds
31.57% Other Institutional Investors
10.65% ETFs
41.03% Public Companies and
Individual Investors
The ownership structure of Enanta Pharmaceuticals (ENTA) stock is a mix of institutional, retail, and individual investors. Approximately 54.21% of the company’s stock is owned by Institutional Investors, 4.76% is owned by Insiders, and 41.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 05, 2025 | xxxxxxxxxxxxx | $19837 | |
Dec 05, 2025 | xxxxxxxxxxxxx | $11356 | |
Dec 05, 2025 | xxxxxxxxxxxxx | $34010 | |
Dec 05, 2025 | xxxxxxxxxxxxx | $29968 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $43718571 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,772,262 | Institution | 9.55% | 36,039,406 | |
| 1,377,167 | Institution | 4.75% | 17,903,171 | |
| 1,284,732 | Institution | 4.43% | 16,701,516 | |
| 1,114,903 | Institution | 3.84% | 14,493,739 | |
| 871,871 | Insider | 3.00% | 11,334,323 | |
| 606,739 | Institution | 2.09% | 7,887,607 | |
| 497,979 | Institution | 1.72% | 6,473,727 | |
| 374,854 | Insider | 1.29% | 4,873,102 | |
| 241,568 | Institution | 0.83% | 3,140,384 | |
| 205,804 | Institution | 0.71% | 2,675,452 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,114,903 | Institution | 3.84% | 14,493,739 | |
| 606,739 | Institution | 2.09% | 7,887,607 | |
| 497,979 | Institution | 1.72% | 6,473,727 | |
| 241,568 | Institution | 0.83% | 3,140,384 | |
| 205,804 | Institution | 0.71% | 2,675,452 | |
| 119,191 | Institution | 0.41% | 1,549,483 | |
| 112,998 | Institution | 0.39% | 1,468,974 | |
| 84,628 | Institution | 0.29% | 1,100,164 | |
| 79,737 | Institution | 0.27% | 1,036,581 | |
| 77,709 | Institution | 0.27% | 1,010,217 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 852,434 | Institution | 2.94% | 12,189,806 | |
| 672,878 | Institution | 2.32% | 8,747,414 | |
| 284,905 | Institution | 0.98% | 4,074,142 | |
| 242,124 | Institution | 0.83% | 3,147,612 | |
| 199,013 | Institution | 0.69% | 2,587,169 | |
| 134,819 | Institution | 0.46% | 1,927,912 | |
| 124,996 | Institution | 0.43% | 1,587,449 | |
| 88,631 | Institution | 0.31% | 1,152,203 | |
| 74,987 | Institution | 0.26% | 952,335 | |
| 72,413 | Institution | 0.25% | 941,369 |
FAQ
Who Owns Enanta Pharmaceuticals (ENTA)?
According to the latest TipRanks data, approximately 31.57% of the company's stock is held by institutional investors, 4.76% is held by insiders, and 41.03% is held by retail investors.
What percentage of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.57% of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors.
What percentage of Enanta Pharmaceuticals (ENTA) stock is held by retail investors?
According to the latest TipRanks data, approximately 41.03% of Enanta Pharmaceuticals (ENTA) stock is held by retail investors.
Who owns the most shares of Enanta Pharmaceuticals (ENTA)?
Andrew J.M. Spokes owns the most shares of Enanta Pharmaceuticals (ENTA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.